Who was sanctioned, and for what?

The Houston laboratory, its former CEO Michael Stewart and the businessman Harold Shatz allegedly paid kickbacks and billed Medicare and Medicaid for medically unnecessary genetic tests. The three settlements add up to 36.4 million USD; the laboratory is subject to a Corporate Integrity Agreement.

Authority / court

U.S. Department of Justice

Area of law

Bribery and corruption · Commercial bribery

Legal basis

Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)); False Claims Act (31 U.S.C. §§ 3729 ff.)

Action

Other

Status of proceedings

final

Sector

Healthcare

Liability of senior managers

Former CEO pays under a separate settlement.

Original amount 36,400,000 USD, converted at the ECB reference rate of 30 Jul 2026.

Checked against the official source on 25 Sep 2026 · Direct link

Report an error

Website What is wrong? Please include evidence if possible.

Anonymous: we store only your text — no contact details and no IP address.

Send report

The Florida laboratory provided referring physicians with consulting services below market value and paid independent consultants referral-based remuneration for recruiting physicians. Following a self-disclosure, NeoGenomics paid 9,813,260 USD.

Authority / court

U.S. Department of Justice

Area of law

Bribery and corruption · Commercial bribery

Legal basis

Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)); False Claims Act (31 U.S.C. §§ 3729 ff.)

Action

Other

Status of proceedings

final

Sector

Healthcare

Mitigating circumstances

Self-disclosure of the remuneration arrangements.

Original amount 9,813,260 USD, converted at the ECB reference rate of 20 Jul 2026.

Checked against the official source on 25 Sep 2026 · Direct link

Report an error

Website What is wrong? Please include evidence if possible.

Anonymous: we store only your text — no contact details and no IP address.

Send report

The Arkansas pathology laboratory, its management company and the owners Kevin Hannah, Donell Burkett and Daniel Hunter Pledger allegedly granted unlawful kickbacks and ordered medically unnecessary tests. Together they paid 30 million USD; the laboratory entered into a Corporate Integrity Agreement.

Authority / court

U.S. Department of Justice

Area of law

Bribery and corruption · Commercial bribery

Legal basis

Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)); False Claims Act (31 U.S.C. §§ 3729 ff.)

Action

Other

Status of proceedings

final

Sector

Healthcare

Liability of senior managers

The owners contribute personally as parties to the settlement.

Original amount 30,000,000 USD, converted at the ECB reference rate of 17 Jun 2026.

Checked against the official source on 25 Sep 2026 · Direct link

Report an error

Website What is wrong? Please include evidence if possible.

Anonymous: we store only your text — no contact details and no IP address.

Send report

The non-profit hospital group Ascension wanted to acquire AmSurg for 3.9 billion USD. Owing to overlaps in outpatient surgery in five regions, the Federal Trade Commission (FTC) requires the sale of seven AmSurg centres to SC Affiliates and a gastroenterology practice, as well as transitional support.

Authority / court

Federal Trade Commission (FTC)

Area of law

Competition law · Merger control

Legal basis

Section 7 Clayton Act; Section 5 FTC Act (Consent Order)

Action

Order

Status of proceedings

unknown

Sector

Healthcare

Employees

10,000 or more

Checked against the official source on 25 Sep 2026 · Direct link

Report an error

Website What is wrong? Please include evidence if possible.

Anonymous: we store only your text — no contact details and no IP address.

Send report

The Californian provider of mobile PET scans allegedly paid referring cardiologists excessive fees for supervising the examinations in order to secure referrals. The settlement of 8,334,350.71 USD plus revenue-based payments is based on ability to pay; in addition, there is a Corporate Integrity Agreement.

Authority / court

U.S. Department of Justice / U.S. Attorney's Office, Central District of California

Area of law

Bribery and corruption · Commercial bribery

Legal basis

Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)); False Claims Act (31 U.S.C. §§ 3729 ff.)

Action

Other

Status of proceedings

final

Sector

Healthcare

Original amount 8,334,350.71 USD, converted at the ECB reference rate of 30 Apr 2026.

Checked against the official source on 25 Sep 2026 · Direct link

Report an error

Website What is wrong? Please include evidence if possible.

Anonymous: we store only your text — no contact details and no IP address.

Send report

Through sham consultancy agreements, fictitious invoices and purported bonus payments, around 602,000 USD in bribes flowed from 2017 to 2023 via a Belgian consultant to a physician in a senior position at a French public hospital, so that the hospital would purchase embolisation coils from Balt. The DOJ declined to prosecute on account of voluntary self-disclosure, cooperation and remediation (declination of 17 March 2026); Balt is disgorging 1,214,797 USD in profits.

Authority / court

U.S. Department of Justice (Criminal Division, Fraud Section)

Area of law

Bribery and corruption · Bribery of public officials

Legal basis

FCPA; Corporate Enforcement and Voluntary Self-Disclosure Policy (Declination)

Action

Disgorgement of profits

Status of proceedings

final

Sector

Healthcare

Culpability

intentional

Mitigating circumstances

Voluntary self-disclosure (including to the French national financial prosecutor's office, PNF), full cooperation, timely remediation, disciplinary measures, parallel resolution in France.

Liability of senior managers

A former manager of the US subsidiary (David Ferrera) and a consultant (Marc Tilman) were charged with FCPA violations and money laundering.

Published

19 Mar 2026

Original amount 1,214,797 USD, converted at the ECB reference rate of 17 Mar 2026.

Checked against the official source on 25 Sep 2026 · Direct link

Report an error

Website What is wrong? Please include evidence if possible.

Anonymous: we store only your text — no contact details and no IP address.

Send report

Between January and June 2023, the Sarasota laboratory paid independent marketers to steer laboratory samples from Medicare beneficiaries to it. It self-disclosed the conduct, cooperated extensively and paid 980,000 USD.

Authority / court

U.S. Attorney's Office, Middle District of Florida

Area of law

Bribery and corruption · Commercial bribery

Legal basis

Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)); False Claims Act (31 U.S.C. §§ 3729 ff.)

Action

Other

Status of proceedings

final

Sector

Healthcare

Mitigating circumstances

Voluntary self-disclosure, detailed disclosure and cooperation.

Original amount 980,000 USD, converted at the ECB reference rate of 5 Mar 2026.

Checked against the official source on 25 Sep 2026 · Direct link

Report an error

Website What is wrong? Please include evidence if possible.

Anonymous: we store only your text — no contact details and no IP address.

Send report

The hospital (until 2015 Hudson Valley Hospital Center) allegedly paid an oncology practice in Westchester millions of dollars to induce it to refer patients to the hospital; the hospital billed the services to Medicare and Medicaid. The U.S. Attorney’s Office filed a complaint and at the same time concluded a settlement of 6.8 million USD.

Authority / court

U.S. Attorney's Office, Southern District of New York

Area of law

Bribery and corruption · Commercial bribery

Legal basis

Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)); False Claims Act (31 U.S.C. §§ 3729 ff.)

Action

Other

Status of proceedings

final

Sector

Healthcare

Original amount 6,800,000 USD, converted at the ECB reference rate of 22 Dec 2025.

Checked against the official source on 25 Sep 2026 · Direct link

Report an error

Website What is wrong? Please include evidence if possible.

Anonymous: we store only your text — no contact details and no IP address.

Send report

According to the FTC, the telemedicine company advertised GLP-1 weight-loss programmes with monthly prices that did not include medication, laboratory costs and medical consultations, concealed the minimum term and cancellation fees, published fake testimonials from employees and relatives, and induced customers to delete negative reviews by offering vouchers or refunds. Under the final settlement order, the company and its management are paying 150,000 USD, which is earmarked for refunds.

Authority / court

Federal Trade Commission (FTC)

Area of law

Consumer protection and online retail · Fake reviews

Legal basis

Section 5 FTC Act; Restore Online Shoppers' Confidence Act (ROSCA)

Action

Disgorgement of profits

Status of proceedings

final

Sector

Healthcare

Liability of senior managers

Founder Robert Epstein and CEO Frank Leonardo III are named in the press release as parties involved.

Published

3 Dec 2025

Original amount 150,000 USD, converted at the ECB reference rate of 3 Dec 2025.

Checked against the official source on 25 Sep 2026 · Direct link

Report an error

Website What is wrong? Please include evidence if possible.

Anonymous: we store only your text — no contact details and no IP address.

Send report

The medical technology manufacturer misled investors about regulatory risks of the Alaris infusion pump, which had more than 25 software defects, and did not record the remediation costs, as a result of which operating income in the fourth quarter of 2019 was overstated by 82 %. BD is paying 175 million USD and must appoint an independent compliance consultant.

Authority / court

U.S. Securities and Exchange Commission (SEC)

Area of law

Capital markets and financial supervision · Disclosure and reporting obligations

Legal basis

Antifraud-, Reporting-, Buchführungs-, interne Kontroll- und Disclosure-Controls-Vorschriften der US-Wertpapiergesetze

Action

Fine

Status of proceedings

final

Sector

Healthcare

Original amount 175,000,000 USD, converted at the ECB reference rate of 16 Dec 2024.

Checked against the official source on 25 Sep 2026 · Direct link

Report an error

Website What is wrong? Please include evidence if possible.

Anonymous: we store only your text — no contact details and no IP address.

Send report

Between July 2019 and July 2023, Acadia Healthcare had employees waive potential awards for reports to authorities in 98 employment, separation, retention and settlement agreements; in 56 further separation and settlement agreements, they had to waive complaints to federal authorities. As part of a sweep against seven listed companies, Acadia paid 1,386,000 US dollars to the U.S. Securities and Exchange Commission (SEC); the contract templates were amended.

Authority / court

U.S. Securities and Exchange Commission

Area of law

Whistleblower protection · Retaliation against whistleblowers

Legal basis

Securities Exchange Act of 1934, Rule 21F-17(a)

Action

Fine

Status of proceedings

final

Sector

Healthcare

Mitigating circumstances

Partial amendment of the templates even before contact by the SEC, information provided to those affected, and cooperation

Published

9 Sep 2024

Original amount 1,386,000 USD, converted at the ECB reference rate of 9 Sep 2024.

Checked against the official source on 25 Sep 2026 · Direct link

Report an error

Website What is wrong? Please include evidence if possible.

Anonymous: we store only your text — no contact details and no IP address.

Send report

The dialysis group allegedly paid kickbacks to promote referrals to its former pharmacy subsidiary DaVita Rx and granted benefits to nephrologists and vascular surgeons to induce them to send patients to DaVita dialysis centres. DaVita paid 34,487,390 USD.

Authority / court

U.S. Department of Justice

Area of law

Bribery and corruption · Commercial bribery

Legal basis

Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)); False Claims Act (31 U.S.C. §§ 3729 ff.)

Action

Other

Status of proceedings

final

Sector

Healthcare

Employees

10,000 or more

Original amount 34,487,390 USD, converted at the ECB reference rate of 18 Jul 2024.

Checked against the official source on 25 Sep 2026 · Direct link

Report an error

Website What is wrong? Please include evidence if possible.

Anonymous: we store only your text — no contact details and no IP address.

Send report

Three home health agencies in Texas, Ohio and Indiana and their parent company allegedly granted kickbacks to assisted living facilities and physicians for Medicare referrals. They paid 4,496,330 USD.

Authority / court

U.S. Department of Justice

Area of law

Bribery and corruption · Commercial bribery

Legal basis

Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)); False Claims Act (31 U.S.C. §§ 3729 ff.)

Action

Other

Status of proceedings

final

Sector

Healthcare

Original amount 4,496,330 USD, converted at the ECB reference rate of 1 Jul 2024.

Checked against the official source on 25 Sep 2026 · Direct link

Report an error

Website What is wrong? Please include evidence if possible.

Anonymous: we store only your text — no contact details and no IP address.

Send report

At the care facility, employees worked up to 24 hours a day, seven days a week, were not allowed to leave the premises, had to work through breaks and received no overtime pay. The settlement of 658,948 USD comprises 608,948 USD for 34 employees (including overtime and break premiums) and 50,000 USD in civil penalties.

Authority / court

California Labor Commissioner's Office (Division of Labor Standards Enforcement)

Area of law

Health and safety and employment law · Working time

Legal basis

California Labor Code (Überstunden, Meal and Rest Periods, Mindestlohn)

Action

Other

Status of proceedings

final

Sector

Healthcare

Original amount 658,948 USD, converted at the ECB reference rate of 12 Jun 2024.

Checked against the official source on 25 Sep 2026 · Direct link

Report an error

Website What is wrong? Please include evidence if possible.

Anonymous: we store only your text — no contact details and no IP address.

Send report

The Utah manufacturer of spinal implants and two executives – founder and president Brent Felix and former CFO Garth Felix – allegedly paid surgeons kickbacks to induce them to use Innovasis products. Together they paid 12 million USD; HHS-OIG placed the company under heightened scrutiny.

Authority / court

U.S. Department of Justice

Area of law

Bribery and corruption · Commercial bribery

Legal basis

Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)); False Claims Act (31 U.S.C. §§ 3729 ff.)

Action

Other

Status of proceedings

final

Sector

Healthcare

Liability of senior managers

Founder/president and former CFO pay personally as parties to the settlement.

Original amount 12,000,000 USD, converted at the ECB reference rate of 29 May 2024.

Checked against the official source on 25 Sep 2026 · Direct link

Report an error

Website What is wrong? Please include evidence if possible.

Anonymous: we store only your text — no contact details and no IP address.

Send report